Picture of Medacta SA logo

MOVE — Medacta SA News Story

0.000.00%
ch flag iconLast trade - 00:00
HealthcareBalancedMid CapFalling Star

Brief: Medacta Sees FY 2023 Adj. EBITDA Margin in Line With 2022

Mar 17 (Reuters) - Medacta FY adjusted EBITDA EUR 120.4 million.
* Outlook for 2023: At constant currency, revenue in the range of EUR 480
million to EUR 495 million and adjusted EBITDA margin largely in line with
2022

Recent news on Medacta SA

See all news